| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.073 | 0.2 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.2 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |